NovaBay Pharmaceuticals (NBY) stock slides premarket after 102% surge — dilution risk back on radar
New York, January 12, 2026, 05:15 EST — Premarket NovaBay Pharmaceuticals, Inc. shares slipped roughly 10% in early Monday trading, falling to $17.21 after finishing Friday at $19.16. This dip comes after a notable surge in the lightly traded stock on the NYSE American. https://stockanalysis.com/stocks/nby/ Friday’s surge was extreme, even for a microcap. Shares closed up 102.5%, swinging between $9.69 and $19.95, on roughly 10 million shares changing hands, according to StockAnalysis data. https://stockanalysis.com/stocks/nby/history/ This is crucial now, as the stock has morphed into a momentum play within just a few sessions. Such trades hinge heavily on share availability. With